The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of fibroblast growth factor receptor (FGFR) genomic alterations and outcomes in patients with metastatic urothelial.
 
Elena Sevillano
Honoraria - Bristol-Myers Squibb; Janssen; MSD; Roche
Speakers' Bureau - Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Rodrigo Madurga
No Relationships to Disclose
 
Juan Francisco Rodriguez Moreno
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Novartis; Rainier Therapeutics
Speakers' Bureau - Astellas Amgen BioPharama; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Pharma+; Roche
Research Funding - Abbvie; Amgen; Aprea Therapeutics; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; MSD; Novartis; Pfizer; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - Astellas Oncology; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Arantzazu Barquin
No Relationships to Disclose
 
Monica Yagüe
No Relationships to Disclose
 
Paloma Navarro
No Relationships to Disclose
 
María Barba
No Relationships to Disclose
 
Miguel Quiralte
No Relationships to Disclose
 
Jesús García-Donas
No Relationships to Disclose